Moore N - Search Results

1

Fibrates and risk of cancer in tissues with high PPAR-α concentration: a nested case-control study.

Salvo F, Bazin F, Kostrzewa A, Bandre C, Robinson P, Moore N, Bégaud B, Pariente A. Salvo F, et al. Among authors: moore n. Drug Saf. 2014 May;37(5):361-8. doi: 10.1007/s40264-014-0157-8. Drug Saf. 2014. PMID: 24743875

2

Does use or withdrawal of long-acting beta 2-adrenoceptor induce desensitisation?

Molimard M, Moore N, Begaud B. Molimard M, et al. Among authors: moore n. Lancet. 1998 Jan 3;351(9095):66-7. doi: 10.1016/S0140-6736(05)78055-7. Lancet. 1998. PMID: 9433446 No abstract available.

3

Is reporting rate a good predictor of risks associated with drugs?

Pierfitte C, Bégaud B, Lagnaoui R, Moore ND. Pierfitte C, et al. Among authors: moore nd. Br J Clin Pharmacol. 1999 Mar;47(3):329-31. doi: 10.1046/j.1365-2125.1999.00881.x. Br J Clin Pharmacol. 1999. PMID: 10215758 Free PMC article.

4

The link between sunshine and phototoxicity of sparfloxacin.

Pierfitte C, Royer RJ, Moore N, Bégaud B. Pierfitte C, et al. Among authors: moore n. Br J Clin Pharmacol. 2000 Jun;49(6):609-12. doi: 10.1046/j.1365-2125.2000.00212.x. Br J Clin Pharmacol. 2000. PMID: 10848726 Free PMC article.

5

Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice.

Moore N, Verschuren X, Montout C, Callens J, Kong SX, Bégaud B. Moore N, et al. Therapie. 2000 Jan-Feb;55(1):133-6. Therapie. 2000. PMID: 10860014

6

Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.

Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B. Lagnaoui R, et al. Among authors: moore n. Eur J Clin Pharmacol. 2000 May;56(2):181-6. doi: 10.1007/s002280050738. Eur J Clin Pharmacol. 2000. PMID: 10877014

7

The role of the clinical pharmacologist in the management of adverse drug reactions.

Moore N. Moore N. Drug Saf. 2001 Jan;24(1):1-7. doi: 10.2165/00002018-200124010-00001. Drug Saf. 2001. PMID: 11219484 Review.

8

Benzodiazepines and hip fractures in elderly people: case-control study.

Pierfitte C, Macouillard G, Thicoïpe M, Chaslerie A, Pehourcq F, Aïssou M, Martinez B, Lagnaoui R, Fourrier A, Bégaud B, Dangoumau J, Moore N. Pierfitte C, et al. Among authors: moore n. BMJ. 2001 Mar 24;322(7288):704-8. doi: 10.1136/bmj.322.7288.704. BMJ. 2001. PMID: 11264208 Free PMC article.

9

Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects.

Moore N, Pierfitte C, Pehourcq F, Lagnaoui R, Bégaud B. Moore N, et al. Clin Pharmacol Ther. 2001 Jun;69(6):445-50. doi: 10.1067/mcp.2001.116147. Clin Pharmacol Ther. 2001. PMID: 11406742

10

Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.

Fourrier A, Letenneur L, Dartigues JF, Moore N, Bégaud B. Fourrier A, et al. Among authors: moore n. Eur J Clin Pharmacol. 2001 Aug;57(5):419-25. doi: 10.1007/s002280100326. Eur J Clin Pharmacol. 2001. PMID: 11599660

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,584 results

Search Page

Filters